Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

77.06 +0.83 (+1.09%)
Official Closing Price Updated: 8:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,564,223
Open 77.22
Bid (Size) 77.10 (1)
Ask (Size) 77.15 (1)
Prev. Close 76.23
Today's Range 74.28 - 77.65
52wk Range 61.78 - 141.50
Shares Outstanding 914,750
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
U.S. Weekly FundFlows Insight Report: Sector-Energy Funds Report $1.3 Billion in Outflows, Fourth Largest on Record
During fund-flows week ended June 22, 2022, investors were overall net sellers of fund assets (including both conventional funds and ETFs) for the second straight week, withdrawing a net $20.1... 
Via Talk Markets
3 Beaten-Down ETFs to Buy Before They Rebound
The charts are improving for these fallen angels, and that makes them all top ETFs to buy for the back half of the year. 
Via InvestorPlace

Performance

YTD
-33.25%
-33.25%
1 Month
+13.78%
+13.78%
3 Month
-14.01%
-14.01%
6 Month
-33.09%
-33.09%
1 Year
-43.87%
-43.87%

More News

Read More
“Should’ve Been Me” Stock Market (And Sentiment Results)
Via Talk Markets
Option Bears Reloading as Bulls Feeling Spry
Via Talk Markets
Stock Drop On June 16, But A Rally May Be Coming After Options Expiration
Via Talk Markets
Do Crispr And Vertex Have A 'Functional Cure' For Blood Diseases?
Via Investor's Business Daily
“Chip Shot” Stock Market (And Sentiment Results)
Via Talk Markets
3 Biotech Stocks to Buy Before They Boom
Via InvestorPlace
Again, Buy ‘Em
Via Talk Markets
As COVID Subsidies, Here are 8 Infectious Diseases That Could Emerge As Potent Threats
Via Benzinga
PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst
Via Benzinga
This Biotech Looks Good With Increased M&A activity
Via Talk Markets
The “Mystery Liquidator Revealed” Stock Market (And Sentiment Results)
Via Talk Markets
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Via Talk Markets
When Will The Stock Market Stop Falling?
Via Talk Markets
Stocks Tank On May 11 With No Bottom In Sight
Via Talk Markets
7 Biotech Stocks With Key Catalysts for May
Via InvestorPlace
Should Biotech Be On The Critical List?
Via Talk Markets
“Threading The Needle” Stock Market (And Sentiment Results)
Via Talk Markets
7 Monster Stock Market Predictions For The Week Of April 25
Via Talk Markets
The “magic Chart” Stock Market (And Sentiment Results)
Via Talk Markets
4 Undervalued Biotech Stocks to Add to Your Buy List
Via InvestorPlace
Healthcare Stocks Lead the Way Up as the Market Fades
Via Talk Markets
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
Via InvestorPlace
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.